Table 1 Characteristics of the study participants.

From: Association of androgen with gender difference in serum adipocyte fatty acid binding protein levels

Variable

Men

Premenopausal women

Postmenopausal women

n

194

132

181

Age (years)

51.48 (43.49–58.89)

44.37 (37.98–48.80)**

56.70 (53.68–59.85)**##

BMI (kg/m2)

23.96 ± 2.90

22.89 ± 3.05**

23.39 ± 2.65*

W (cm)

85.35 ± 8.69

77.32 ± 8.68**

80.64 ± 8.18**##

Body composition

   

 Total

FM (kg)

14.53 ± 5.27

18.33 ± 5.99**

19.59 ± 5.21**

 

fat%

19.97 ± 5.02

30.55 ± 5.93**

32.48 ± 4.92**##

 Trunk

FM (kg)

8.04 ± 3.23

9.70 ± 3.70**

10.71 ± 3.25**#

 

fat%

20.73 ± 6.27

29.00 ± 7.22**

31.82 ± 5.85**##

 Arm

FM (kg)

1.10 (0.80–1.40)

1.40 (1.00–1.98)**

1.60 (1.20–2.00)**

 

fat%

15.25 (13.35–17.96)

27.29 (23.19–33.19)**

30.13 (26.23–33.04)**#

 Leg

FM (kg)

5.38 ± 1.76

7.07 ± 1.73**

7.26 ± 1.54**

 

fat%

20.50 (17.97–22.51)

33.00 (30.26–36.60)**

34.50 (32.12–36.53)**

SBP (mmHg)

120.00 (112.00–130.00)

110.00 (104.00–121.17)**

120.00 (110.00–130.00)##

DBP (mmHg)

80.00 (74.50–89.33)

78.67 (70.00–80.67)**

79.33 (70.00–85.33)**

FPG (mmol/L)

5.21 (4.88–5.53)

5.23 (4.89–5.60)

5.17 (4.88–5.47)

2hPG (mmol/L)

6.84 ± 1.81

6.17 ± 1.57**

6.90 ± 1.61##

HbA1c (%)

5.5 (5.3–5.7)

5.5 (5.3–5.7)

5.7 (5.5–5.9)**##

FINS (mU/L)

6.22 (4.30–9.09)

5.87 (4.32–8.17)

6.69 (4.94–9.60)#

HOMA-IR

1.44 (0.93–2.29)

1.42 (0.94–1.96)

1.54 (1.10–2.32)

TC (mmol/L)

4.91 ± 0.85

4.80 ± 0.90

5.65 ± 0.96**##

TG (mmol/L)

1.42 (0.90–1.95)

0.91 (0.65–1.33)**

1.30 (0.94–1.75)##

HDL-c (mmol/L)

1.32 ± 0.30

1.57 ± 0.31**

1.57 ± 0.32**

LDL-c (mmol/L)

2.96 ± 0.79

2.79 ± 0.77

3.40 ± 0.78**##

CRP (mg/L)

0.61 (0.33–1.21)

0.44 (0.16–0.87)**

0.69 (0.37–1.52)##

Alb (g/L)

48.00 (47.00–50.00)

47.00 (46.00–49.00)**

48.00 (46.00–49.00)**

A-FABP (ng/mL)

3.04 (1.80–4.08)

3.37 (2.36–5.16)**

5.50 (3.80–6.71)**##

E2 (pmol/L)

88.08 (66.06–113.77)

264.24 (128.45–450.49)**

18.35 (18.35–36.70)**##

TT (nmol/L)

19.83 (16.86–24.58)

2.03 (1.56–2.56)**

1.67 (1.28–2.05)**##

FT(nmol/L)

0.37 (0.31–0.44)

0.02 (0.02–0.03)**

0.02 (0.01–0.03)**

BT(nmol/L)

9.93 (8.19–11.34)

0.63 (0.40–0.90)**

0.55 (0.38–0.77)**

SHBG (nmol/L)

35.45 (27.73–50.93)

58.00 (43.03–84.35)**

52.60 (35.95–72.90)**#

  1. Abbreviation: BMI: body mass index; W: waist circumference; FM: fat mass; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; 2hPG: 2-hour plasma glucose; HbA1c: glycated hemoglobin A1c; FINS: fasting serum insulin; HOMA-IR: Homeostasis model assessment-insulin resistance; TC: total cholesterol; TG: triglyceride; HDL-c: high density lipoprotein cholesterol; LDL-c: low density lipoprotein cholesterol; CRP: C-reactive protein; Alb: albumin; A-FABP: adipocyte fatty acid binding protein; E2: Estradiol; TT: total testosterone; FT: free testosterone; BT: bioavailable testosterone; SHBG: sex hormone-binding globulin.
  2. Data are expressed as means ± SD or median (interquartile range).
  3. *P < 0.05 versus men; **P < 0.01 versus men; #P < 0.05 versus premenopausal women; ##P < 0.01 versus premenopausal women.
Back to article page